Overexpression of EGFR and Her-2 have been reported to be associated with higher grades or reduced survival in a variety of cancers, including breast, colorectal, and head and neck cancers (for a review, see Klijn et al, 1992; Salomon et al, 1995). The gene discussed is ERBB2; the disease is head and neck cancer.